|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular & Cellular Proteomics 4:936-944, 2005.
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc.
,
,¶,||









,¶¶
,
,¶,||||
From the
Organelle Signaling Laboratory, Department of Surgery and ¶ Montreal Proteomics Network, McGill University, Montreal, Quebec H3A 2B2, Canada, the ** Laboratoire de Combinatoire et dInformatique Mathématique, University of Quebec at Montreal, Montreal, Quebec H3C 3P8, Canada, 
PerkinElmer BioSignal, Montreal, Quebec H3J 1R4, Canada, and the 
Centre for Cancer Systems Biology and Department of Cancer Biology, Dana-Farber Cancer Institute and the Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115
| ABSTRACT |
|---|
|
|
|---|
The analysis of full genome sequences has allowed large scale biology experimental approaches consisting of systematic characterization of entire families of proteins instead of investigating them individually. Developing such "functional proteomic" approaches requires the design of high throughput and versatile experimental procedures (7, 8). For the study of small G proteins, conventional filtration assays, although powerful at small scale, are not appropriate for systematic studies. Indeed this methodology has a low to very low throughput, is not versatile, and requires large amounts of reagents. To overcome these issues and characterize GTP-binding proteins of the Ras superfamily in a systematic manner, we developed a robust assay platform using two well adopted high throughput technologies, AlphaScreenTM (9) and FlashPlate® (10).
AlphaScreen is a bead-based non-radioactive and homogenous proximity assay used to measure interaction between biological binding partners. The principle of this technology relies on the use of a Donor bead and an Acceptor bead that generate a light signal when brought into proximity (<200 nm). Upon laser excitation at 680 nm, the Donor beads, containing a photosensitizer, will generate short lived singlet oxygen that can diffuse only a short distance before returning to the ground state. The Acceptor beads, containing chemiluminescers and fluorophores, will react with this singlet oxygen and will emit an amplified light signal measurable at
600 nm. AlphaScreen (PerkinElmer) provides highly versatile, sensitive, and homogeneous assays that allow us to perform studies at a higher throughput and at a lower cost.
FlashPlates are white polystyrene microplates in which the interior of wells is coated with a thin layer of polystyrene-based scintillation reagent. The principle of this homogeneous radiometric technology is based on proximity between a radioligand and the scintillation reagent. A target protein, such as antibodies or GSH, is also labeled on the wall of the plate and will bring the protein of interest close to the scintillation reagent. The interaction between the radioisotopes and the proteins of interest will activate the scintillation reagent and emit a luminescent signal. FlashPlate (PerkinElmer) technology reduces considerably the amount of reagent to use and eliminates the time-consuming washes normally needed to separate bound from unbound radioligands.
In this study we took advantage of these two technologies to characterize in a systematic manner four biochemical properties of the Ras family of small G proteins and we reclassified them according to their activities instead of their primary amino acid sequences. Due to their high level of interspecies conservation, we selected the Rho GTPases as prototype proteins to develop and validate our assays.
| EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
-35S]GTP
S and [
-33P]GTP were purchased form PerkinElmer Life Sciences. ATP, GDP, GTP, and GTP
S1 were purchased form Sigma. Goat anti-GST antibodies were from Amersham Biosciences.
Plasmids and Constructs
Caenorhabditis elegans CDC-42 (RO7G3.1), RAC-2 (KO3D3.10b), CED-10 (C09G12.8b), MIG-2 (C35C5.4), and RHO-1 (Y51H4A.3) plus one putative uncharacterized GTPase, CRP-1 (Y32F6B.3), were obtained from the C. elegans ORFeome (11). The mRAC-1 and mRAC-1N17 were described previously (12). The above ORFs were recombined in a bacterial expression vector (pGEX-2TK) to produce N-terminally tagged GST fusion proteins using the Gateway technology (Invitrogen).
Nucleotide Biotinylation
GTP
S and GDP were biotinylated, respectively, using biotin-PEG-maleinate (Pierce) dissolved in MES, pH 6, and biotin-PEG-COO-NHS (Pierce) dissolved in carbonate buffer, pH 8.5, according to the manufacturers instructions. For both nucleotides, reaction mixtures were incubated for 2 h at 37 °C and purified using HPLC. Concentrations were measured by optical density at 260 nm. Biotinylated nucleotides were validated for their biological properties toward GTPases (data not shown).
Expression and Purification of Recombinant Proteins
Bacterial recombinant GST-GTPases were expressed and purified as described previously (13).
AlphaScreen Assays
AlphaScreen assays were performed in Costar 384-well microplates in a final reaction volume of 25 µl. Streptavidin Donor beads and protein G Acceptor beads (PerkinElmer BioSignal) were used at a final concentration of 0.02 mg/ml per well. The assays were performed in AlphaScreen buffer (50 mM HEPES, pH 7.4, 100 mM NaCl, 5 mM MgCl2, 1 mM DTT, and 1 mg/ml BSA). All incubations were performed at 23 °C. Laser excitations were carried out at 680 nm, and readings were performed at 520620 nm using an AlphaQuest reader (Packard).
Competition Assays
During purification, GST-GTPases were unloaded from their intrinsic nucleotide by adding 5 mM EDTA in lysate before purification. Different concentrations of nucleotides (ranging from 0.4 nM to 3 µM) were incubated with a 30 nM concentration of unloaded GST-GTPases and a 30 nM concentration of a biotinylated derivative of GTP
S (b-GTP
S). 25 nM goat anti-GST antibody (Amersham Biosciences) was added and incubated for 20 min. Donor and Acceptor beads were added simultaneously and incubated for 1 h before reading.
Exchange Activity
Purified GST-GTPases were preloaded with a biotinylated derivative of GDP (b-GDP) as follows. 150 nM proteins were incubated with 100 nM b-GDP in loading buffer (25 mM Tris, pH 7.4, 100 mM NaCl, 0.1 mM DTT, and 5 mM EDTA) for 30 min at 30 °C. Reactions were then placed on ice, and 10 mM MgCl2 was added. 5 µl of preloaded GST-GTPases (final concentration, 30 nM) were then added in microplate wells with different concentration of unlabeled GTP (ranging from 0.4 nM to 3 µM). The plate was incubated for 20 min, and 25 nM goat anti-GST (Amersham Biosciences) was added. After 20 min of incubation, Donor and Acceptor beads were added simultaneously, and the plate was analyzed after 1 h of incubation at 23 °C.
FlashPlate Assays
These assays were performed in glutathione-coated 96-wells FlashPlates (PerkinElmer). Bacterial lysates containing GST-GTPases were diluted with PBS (50 µl) and incubated in the FlashPlate for 45 min at 4 °C in the presence of 5 mM EDTA to allow the binding of GST-GTPases on the GSH plate and to unload the protein from its intrinsic nucleotide.
Binding Assay
The lysate was removed, and the wells were washed two times with loading buffer (20 mM Tris, pH 7.4, 100 mM NaCl, and 0.1 mM DTT). Then 50 µl of loading buffer containing different concentrations of [
-35S]GTP
S (201000 nCi) were added. The signal produced was monitored on a ß scintillation counter (Packard) every 5 min until the plateau was reached. The plate was placed back on ice, and 10 mM MgCl2 was added. The radioactive reaction mixture was then removed from the plate, and 50 µl of stopping buffer (20 mM Tris, pH 7.4, 0.1 mM DTT, 5 mM MgCl2, 1 mg/ml BSA, and 100 µM GTP
S) were added. Signal was monitored on a ß scintillation counter (Packard) every 5 min for another 30 min to measure nucleotide dissociation.
Hydrolysis Activity
Bacterial lysate containing EDTA was replaced by 50 µl of loading buffer (20 mM Tris, pH 7.4, 100 mM NaCl, and 0.1 mM DTT) containing either 500 nCi of [
-35S]GTP
S or 500 nCi of [
-33P]GTP. The interaction between GTPases and these radionucleotides was carried out for 30 min after which 10 mM MgCl2 was added. The radioactive reaction mixture was then replaced by 50 µl of hydrolysis buffer (20 mM Tris, pH 7.4, 100 mM NaCl, 5 mM MgCl2, 1 mM DTT, 0.01% BSA, and 1 µM GTP), and the radioactivity was monitored for another 60 min using a ß scintillation counter (Packard).
Data Clustering, Tree Representation, and Comparison
C. elegans GTPase amino acid sequences were aligned using ClustalW (Blosum30 (Henikoff) matrix).2 Matrices were computed from the alignment using PHYLIP ProtDist according to the Jones-Taylor-Thornton model. The hierarchical clustering tree was then computed using the PHYLIP Neighbor command based on the UPGMA method and visualized using TreeView. Biochemical values obtained for each GTPase were normalized (between 0 and 1) and used to generate distance matrices based on activity(ies) similarities (alone or in combination). These matrices were calculated based on Euclidian distances, and hierarchical clustering trees were then computed using the PHYLIP Neighbor command based on the UPGMA method and visualized using TreeView. Tree comparison was carried out using PHYLIP Treedist.
| RESULTS |
|---|
|
|
|---|
). The GST fusion proteins were expressed at high levels and purified to homogeneity (Fig. 1B). Using these small G proteins, we developed four distinct assays to measure their affinity for guanine nucleotides as well as their exchange and hydrolysis activities.
|
-35S]GTP
S were incubated in the presence of a constant amount of nucleotide-free GST-GTPase. GST alone was also used as a negative control (see "Experimental Procedures"; Fig. 2A). When [
-35S]GTP
S interacts with the proteins associated with the plate, ß particles emitted from 35S activate the scintillation reagent embedded in the walls of the microplate. A luminescent signal is then emitted and measured. As shown in Fig. 2B, the signal intensity increased proportionally to the radionucleotide concentration and reached a plateau. An apparent Kd (Kd(app)) corresponding to the concentration of [
-35S]GTP
S necessary to reach 50% of the maximum signal was measured (Fig. 2B) in a prototypical experiment using CDC-42 (Kd(app) = 7.2 nM). Kd(app) values obtained with the six C. elegans putative Rho GTPases (CDC-42, CED-10, RAC-2, RHO-1, CRP-1, and MIG-2) were then compared together to set a rank order of GTPase GTP binding potency. In addition, the well characterized mRAC-1 (12, 16) and the GTP binding-deficient mutant mRAC-1N17 (17) were used as controls. Our results show that these proteins clustered in two groups according to their affinity toward GTP
S: on one hand CDC-42, RAC-2, CED-10, RHO-1, and mRAC-1 showed a high [
-35S]GTP
S binding with Kd(app) values ranging from 2.8 to 7.4 nM, and on the other hand MIG-2, CRP-1, and mRAC-1N17 showed a low affinity for [
-35S]GTP
S with Kd(app) ranging from 11.7 to 14.5 nM (Fig. 2C). The results obtained with mRAC-1N17 were consistent with previous reports showing that this mutant displays low GTP affinity (17).
|
S was produced and used as a tracer binding to GTP-unloaded GST-GTPases as described under "Experimental Procedures." In our system, the binding of b-GTP
S to GST-GTPases brings anti-GST Acceptor beads into proximity of streptavidin-coated Donor beads thus allowing the generation of an AlphaScreen signal (Fig. 3A). Competition isotherms are generated by adding increasing concentrations of unlabeled nucleotides, which progressively prevent b-GTP
S binding to GST-GTPase. A concentration-dependent signal decrease is then observed (Fig. 3B). Competition curves with GTP were used to generate IC50 values, which are apparent affinity constants: an IC50 value corresponds to the GTP concentration inducing 50% of signal loss. As shown in Fig. 3B, GTP competed the binding of b-GTP
S to CDC-42 with an IC50 value of 45 nM. IC50 values specific for each GTPases were then measured except for mRAC-1N17 for which an outranged signal was detected due to its expected low affinity for b-GTP
S. When the IC50 values were compared together, Rho GTPases clustered in the same two groups previously reported with saturation binding studies using the FlashPlate. High affinity Rho GTPases showed IC50 values ranging from 11.8 to 33.5 nM, whereas the lowest affinity Rho GTPases generated IC50 values varying from 97.6 to 294.5 nM (Fig. 3C). ATP was used as a nonspecific nucleotide control. As expected, ATP was not able to compete the binding of b-GTP
S to the GTPases. In all the assays, GST was included as another negative control to measure background level.
|
S binding assay, exchange of b-GDP to GTP led to a signal decrease. The exchange activity was also characterized by an IC50 value obtained when increasing concentrations of GTP were used to compete the binding of b-GDP to a Rho GTPase such as CDC-42 (Fig. 4B). The IC50 value corresponds to the concentration of GTP necessary for dissociating 50% of the b-GDP initially bound. To compare exchange activities for various GTPases, the specific activity of the GTPases was measured, and a similar amount of GTPase·b-GDP complexes was used in the assay. Parallel analyses of the exchange activities displayed by the Rho GTPases showed that CDC-42, RAC-2, CED-10, RHO-1, and mRAC-1 have high exchange activities with IC50 values ranging from 0.65 to 13.3 nM, whereas MIG-2 and mRAC-1N17 showed lower exchange activities (IC50 values of 49 and 2000 nM, respectively) consistent with their lower affinity for GTP (Fig. 4C). No significant exchange activity was detected for CRP-1. This phenomenon is attributable to the lower affinity of this protein to GTP. Additional experiments to measure the relative affinity of the GTPases for nucleotides using competition assay (as in Fig. 3A) revealed that CRP-1 had a lower affinity for the GTP than GDP (Supplemental Fig. 2B). These results were consistent with the data previously obtained using filtration assay and showing that CRP-1 had a very low exchange activity and atypical characteristics (18).
|
-33P]GTP, and the level of radionucleotide associated with the GTPases was measured as a function of time (Fig. 5A). The signal decrease observed is produced from a combination of hydrolysis of the [
-33P]GTP and dissociation of the nucleotide. To account for the latter, GTP dissociation from the GTPase was measured independently after loading with a non-hydrolyzable GTP analog, [
-35S]GTP
S. The pharmacodynamic parameter measured is the half-life of radionucleotide binding to the Rho GTPases. This parameter corresponds to the time required to achieve 50% hydrolysis after signal correction to account for nucleotide dissociation. A prototypical experiment using CDC-42 revealed that this protein has a high hydrolysis activity (half-life = 10.4 min; Fig. 5B). In our assay, CDC-42, RAC-2, CED-10, MIG-2, and mRAC-1 showed comparable hydrolysis activities with half-lives ranging from 12.0 to 14.1 min, whereas RHO-1 and CRP-1 clustered in another group with half-lives of 41.4 and 95.8 min, respectively (Fig. 5C). Our results were consistent with those reported in the literature for several Rho GTPases using conventional filtration assays (Supplemental Table 1 and Ref. 21).
|
S competition underlined the lower affinity of MIG-2 and CRP-1 for GTP
S. These two GTPases clustered in a separate group from the rest of the RHO GTPases tested (Fig. 6, A and B). Similarly the exchange activity-based tree (Fig. 6C) demonstrated that MIG-2 segregated from the others GTPases, and the hydrolysis activity-based tree showed the partitioning of CRP-1 and RHO-1 from the rest of the GTPases (Fig. 6D). Interestingly these observations correlate with the fact that CRP-1 and RHO-1 are the RHO GTPases with the most deviant P-loop, which is critical for GTP hydrolysis (Fig. 1B).
|
| DISCUSSION |
|---|
|
|
|---|
-35S]GTP
S binding as well as the [
-33P]GTP hydrolysis activity. When compared with more traditional filtration methods, FlashPlate provided a high throughput tool to follow in a homogenous manner the hydrolysis activity of small G proteins. We used AlphaScreen and FlashPlate in combination to cover the entire spectrum of small G protein enzymatic activities. Significant results were obtained for six C. elegans and two mouse GTPases of the Rho family. In addition, comparing the biochemical activities of CED-10 and its mouse ortholog mRAC-1 revealed that these two proteins displayed similar affinity for GTP as well as GDP/GTP exchange and GTP hydrolysis activities (Figs. 25) even if they share only 83% identity in their amino acid sequence (Fig. 1B). Finally activities obtained for mRAC-1, CED-10, and CDC-42 were comparable to those described in the literature (5, 16, 1820). These observations taken together confirmed that (i) our novel approach provides results comparable in significance to the data previously reported from other studies, (ii) these results are comparable between orthologous proteins, (iii) our experimental platform allows a high coverage of the enzymatic activities of the small G protein, and (iv) our assays are sensitive and reproducible enough to identify subtle enzymatic differences between members of the Ras superfamily of proteins.
This analytical platform would have been incomplete without the tools enabling an integrated analysis of our experimental data. We computed hierarchical trees reporting amino acid sequence proximity between groups of proteins. Using a similar concept, we built hierarchical clustering trees reporting the distance between protein groups based on their biochemical characteristics. The comparison of the amino acid sequence-based and the biochemistry-based trees allowed us to demonstrate that sequence similarity only partially represents the functional characteristics of small G proteins. In addition, we were able to indicate that the amino acid sequence-based trees reflect mostly the combination of two biochemical characteristics, namely the affinity for GTP and the GTP hydrolysis activity. Thus, our analytical platform allowed us to propose an alternative classification of the Rho GTPases based on their enzymatic characteristics.
In this study, we established and designed a platform combining AlphaScreen and FlashPlate technologies to assess the enzymatic characteristics of small GTPases of the Ras superfamily. The proof of concept validation of these assays was made possible by using the subfamily of Rho GTPases from both murine and C. elegans origins. This platform may present several advantages applicable to academic research, for example to study the relationships between phylogeny and functional characteristics by a parallel study of many different proteins from the same phyla. On the other hand this type of platform may be profitable to the industrial/pharmaceutical sector for the screening of GTPase inhibitors/activators. The targeting of specific characteristics such as exchange or hydrolysis activities may therefore represent a specific application of this platform.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
Published, MCP Papers in Press, April 6, 2005, DOI 10.1074/mcp.M500025-MCP200
1 The abbreviations used are: GTP
S, guanosine 5'-3-O-(thio)triphosphate; b-GDP, biotinylated GDP; SB, sequence-based; b-GTP
S, biotinylated GTP
S; PEG, polyethylene glycol; NHS, N-hydroxysuccinimide; UPGMA, unweighted pair-group method arithmetic averaged; mRAC-1, mouse RAC-1. ![]()
2 See www.ebi.ac.uk/clustalw/; EMBL-EBI, ClustalW submission form. ![]()
* This work was partially supported by Canadian Institutes for Health Research Grant MOP53357(to E. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. ![]()
S The on-line version of this manuscript (available at http://www.mcponline.org) contains supplemental material. ![]()
Recipients of salary awards from the Fonds de la Recherche en Santé du Québec. ![]()
|| Supported by a grant from the Genome Quebec project to The Cell Map Project (Montreal Proteomics Network). ![]()
¶¶ To whom correspondence may be addressed. Tel.: 514-937-1010 (ext. 230); E-mail: roger.bosse{at}perkinelmer.com
|||| To whom correspondence may be addressed. Tel.: 514-934-1934 (ext. 35468); Fax: 514-843-1411; E-mail: eric.chevet{at}mcgill.ca
| REFERENCES |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Journal of Lipid Research | ASBMB Today |